{
    "nctId": "NCT01314144",
    "briefTitle": "Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery",
    "officialTitle": "Does Continuous Wound Infusion of 0.2% Bupivacaine Provide Superior Analgesia Compared to Standard Opioid-based Therapy in Patients Following Axillary Clearance Surgery?",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 42,
    "primaryOutcomeMeasure": "Pain on abducting the arm on the operative side to 90 degrees as measured using a 100mm visual analogue scale at 6 hours following surgery.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing axillary clearance surgery\n* ASA physical status I - III\n\nExclusion Criteria:\n\n* Patient refusal\n* Pre-existing pain conditions\n* Regular use of opioid analgesia\n* Pregnancy\n* Severe cardiac, renal or hepatic disease\n* Psychiatric illness precluding ability to give informed consent\n* Intercurrent neurological disease\n* Contraindications to bupivacaine or morphine use",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}